The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma.
Saved in:
| Title: | The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma. |
|---|---|
| Authors: | de la Fuente MI; Department of Neurology, University of Miami, Miami, Florida, USA.; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA., Touat M; Service de Neuro-oncologie, Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, Paris Brain Institute, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Paris, France.; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van den Bent MJ; Service de Neuro-oncologie, Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, Paris Brain Institute, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Paris, France.; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Peters KB; Department of Neurosurgery, Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, USA., Young RJ; Service Neuroradiology, Department of Radiology, Memorial Sloan Kettering Cancer, New York, New York, USA., Huang RY; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Capper D; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Berlin, Heidelberg, Germany.; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Phillips JJ; Department of Pathology, University of California San Francisco, San Francisco, California, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA., Halasz LM; Department of Radiation Oncology, University of Washington/Fred Hutchinson Cancer Center, Seattle, Washington, USA., Shih HA; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Rudà R; Division of Neuro-Oncology, Department of Neuroscience, University of Turin, Turin, Italy., Lim-Fat MJ; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Blumenthal DT; Neuro-Oncology, Tel Aviv Medical Center, Tel-Aviv University, Tel-Aviv, Israel., Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Arakawa Y; Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan., Whittle JR; Department of Medical Biology, University of Melbourne, Parkville, Australia.; Personalised Oncology Division, WEHI, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Ducray F; Department of Neuro-Oncology, East Group Hospital, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard, Lyon, France., Reardon DA; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Minniti G; IRCCS Neuromed, Pozzilli, Isernia, Italy.; Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Rome, Italy., Rahman R; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hervey-Jumper S; Department of Neurological Surgery, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.; Department of Pathology, University of California San Francisco, San Francisco, California, USA., Chang SM; Division of Neuro-Oncology, Department of Neurosurgery, University of California, San Francisco, California, USA., Wen PY; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2025 Jun 21; Vol. 27 (5), pp. 1135-1148. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noae259 |
